GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$41.11 USD
+0.20 (0.49%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $41.12 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Earnings News For GSK
-
GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
GSK Gears Up for Q1 Earnings: Here's What to Expect
-
Glaxo (GSK) Up 3.1% Since Last Earnings Report: Can It Continue?
-
GSK (GSK) Misses Q4 Earnings Estimates
-
Glaxo: Q4 Earnings Snapshot
-
GSK Gears Up for Q4 Earnings: Will It Surpass Estimates?
-
GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth
-
Why Is Glaxo (GSK) Up 5.3% Since Last Earnings Report?
-
GSK Beats on Q3 Earnings and Sales, Raises 2023 Guidance
-
GSK (GSK) Q3 Earnings and Revenues Surpass Estimates
-
Glaxo: Q3 Earnings Snapshot
-
GSK (GSK) Expected to Beat Earnings Estimates: Should You Buy?
-
GSK Gears Up for Q3 Earnings: Will It Surpass Estimates?
-
Glaxo (GSK) Down 3.9% Since Last Earnings Report: Can It Rebound?
-
GSK Beats on Q2 Earnings & Sales, Raises 2023 Guidance
-
GSK (GSK) Surpasses Q2 Earnings and Revenue Estimates
-
Glaxo: Q2 Earnings Snapshot
-
GSK Gears Up for Q2 Earnings: Will It Surpass Estimates?
-
GSK (GSK) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
GSK Beats on Q1 Earnings, Lags Sales, Reaffirms 2023 Outlook
-
GSK (GSK) Tops Q1 Earnings Estimates
-
Glaxo: Q1 Earnings Snapshot
-
GSK Gears Up to Report Q1 Earnings: What's in the Cards?
-
Glaxo (GSK) Down 1.6% Since Last Earnings Report: Can It Rebound?
-
GSK's Beats on Q4 Earnings & Sales, Issues Upbeat 2023 Outlook